OncoNano Medicine

Dallas, TX · Founded 2014 · Privately Held (backing)

Developer of a nanotechnology platform designed to improve the delivery and activation of cancer therapies in acidic tumor environments. OncoNano Medicine is based in Dallas, TX and was founded in 2014. It was valued at $60 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $117 million across 3 recorded rounds; the latest was a $12.7 million early-stage round in Apr 2025.

PMV mark · valuation
$60.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$116.5M
Last round
Early Stage VC
Apr 2025

Who backs OncoNano Medicine?

9 investors
InvestorType
National Institutes of HealthOther
AG Collective Capital—
Advantech Capital Partners—
CKG Management—
Cancer Prevention and Research Institute of Texas—
Green Park & Golf Ventures—
Houston Angel Network—
Salem Partners—
U.S. Department of Health and Human Services—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

OncoNano Medicine investors

9 investors are on record for OncoNano Medicine, including National Institutes of Health, AG Collective Capital, Advantech Capital Partners and CKG Management. The early-stage round in Apr 2025 drew 25 investors.

Free account
More of OncoNano Medicine with a free account
  • ·Watch OncoNano Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like OncoNano Medicine. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View